Literature DB >> 25448634

Capsular polysaccharide of Group B Streptococcus mediates biofilm formation in the presence of human plasma.

Fan Di Xia1, Adeline Mallet2, Elise Caliot1, Cherry Gao1, Patrick Trieu-Cuot1, Shaynoor Dramsi3.   

Abstract

Group B Streptococcus (GBS) is an asymptomatic colonizer of human mucosal surfaces that is responsible for sepsis and meningitis in neonates. Bacterial persistence and pathogenesis often involves biofilm formation. We previously showed that biofilm formation in medium supplemented with glucose is mediated by the PI-2a pilus. Here, biofilm formation was tested in cell culture medium supplemented with human plasma. GBS strains were able to form biofilms in these conditions unlike Group A Streptococcus (GAS) or Staphylococcus aureus. Analysis of mutants impaired for various surface components revealed that the GBS capsule is a key component in this process.
Copyright © 2014 Institut Pasteur. Published by Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Biofilm; Capsular polysaccharide; GBS; Human plasma; Streptococcus

Mesh:

Substances:

Year:  2014        PMID: 25448634     DOI: 10.1016/j.micinf.2014.10.007

Source DB:  PubMed          Journal:  Microbes Infect        ISSN: 1286-4579            Impact factor:   2.700


  12 in total

1.  Potential Risk of Spreading Resistance Genes within Extracellular-DNA-Dependent Biofilms of Streptococcus mutans in Response to Cell Envelope Stress Induced by Sub-MICs of Bacitracin.

Authors:  Ryo Nagasawa; Tsutomu Sato; Nobuhiko Nomura; Tomoyo Nakamura; Hidenobu Senpuku
Journal:  Appl Environ Microbiol       Date:  2020-08-03       Impact factor: 4.792

2.  Human Milk Oligosaccharides Exhibit Antimicrobial and Antibiofilm Properties against Group B Streptococcus.

Authors:  Dorothy L Ackerman; Ryan S Doster; Jörn-Hendrik Weitkamp; David M Aronoff; Jennifer A Gaddy; Steven D Townsend
Journal:  ACS Infect Dis       Date:  2017-06-13       Impact factor: 5.084

Review 3.  Group B Streptococcal Maternal Colonization and Neonatal Disease: Molecular Mechanisms and Preventative Approaches.

Authors:  Kathryn A Patras; Victor Nizet
Journal:  Front Pediatr       Date:  2018-02-22       Impact factor: 3.418

Review 4.  Group B Streptococcal Colonization, Molecular Characteristics, and Epidemiology.

Authors:  Sarah Shabayek; Barbara Spellerberg
Journal:  Front Microbiol       Date:  2018-03-14       Impact factor: 5.640

Review 5.  A Vaccine Against Group B Streptococcus: Recent Advances.

Authors:  Clara Carreras-Abad; Laxmee Ramkhelawon; Paul T Heath; Kirsty Le Doare
Journal:  Infect Drug Resist       Date:  2020-04-29       Impact factor: 4.003

6.  Distribution of Pilus island and antibiotic resistance genes in Streptococcus agalactiae obtained from vagina of pregnant women in Yazd, Iran.

Authors:  Mahdieh Nabavinia; Mohammad Bagher Khalili; Maryam Sadeh; Gilda Eslami; Mahmood Vakili; Nastaran Azartoos; Mahdiye Mojibiyan
Journal:  Iran J Microbiol       Date:  2020-10

7.  Antimicrobial and Antibiofilm Activity of Human Milk Oligosaccharides against Streptococcus agalactiae, Staphylococcus aureus, and Acinetobacter baumannii.

Authors:  Dorothy L Ackerman; Kelly M Craft; Ryan S Doster; Jörn-Hendrik Weitkamp; David M Aronoff; Jennifer A Gaddy; Steven D Townsend
Journal:  ACS Infect Dis       Date:  2017-12-08       Impact factor: 5.084

8.  Pan-GWAS of Streptococcus agalactiae Highlights Lineage-Specific Genes Associated with Virulence and Niche Adaptation.

Authors:  Andrea Gori; Odile B Harrison; Ethwako Mlia; Yo Nishihara; Jia Mun Chan; Jacquline Msefula; Macpherson Mallewa; Queen Dube; Todd D Swarthout; Angela H Nobbs; Martin C J Maiden; Neil French; Robert S Heyderman
Journal:  mBio       Date:  2020-06-09       Impact factor: 7.867

9.  Phenotypic and molecular analysis of nontypeable Group B streptococci: identification of cps2a and hybrid cps2a/cps5 Group B streptococcal capsule gene clusters.

Authors:  Areej Alhhazmi; Gregory J Tyrrell
Journal:  Emerg Microbes Infect       Date:  2018-08-08       Impact factor: 7.163

10.  Progress toward a group B streptococcal vaccine.

Authors:  Joon Young Song; Jae Hyang Lim; Sangyong Lim; Zhi Yong; Ho Seong Seo
Journal:  Hum Vaccin Immunother       Date:  2018-07-16       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.